Skip to main content

Week In Review: SinoMab To IPO On Hong Kong Exchange

Hong Kong's SinoMab published its prospectus for a Hong Kong IPO to support its antibody program for autoimmune and oncology mAbs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.